Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology - Wikidata - awgldk - TriplyDB

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

http://www.wikidata.org/entity/Q26785420

about

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany.Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.

P2860

Q37069371-4BC3D823-EAF1-4981-8E36-4DCAE2FD9E0B Q38754668-4CFBA36A-087A-49B5-8149-CD80BD17D6BA

P2860

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

http://www.wikidata.org/entity/Q26785420

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@ast

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@en

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@nl

type

label

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@ast

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@en

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@nl

prefLabel

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@ast

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@en

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@nl

P1433

Q26785420-A521CC5B-AC28-406D-8F85-A621CC36C122

P1476

Q26785420-4BC658DF-BD0C-4C6C-B12B-B818546C9558

P2093

Q26785420-3E48C072-6208-4A7B-A255-CA8B671CA22F

Q26785420-4EA8DDEE-9591-49C6-AF8E-8455CC0694F6

Q26785420-B04FB900-D809-49A8-B161-28B9AEBF7D45

Q26785420-F5B9DFF0-1BA5-448F-9774-5233AF49BAF3

Q26785420-F974D161-D1ED-4584-A893-6CAA98F37623

P275

Q26785420-87D17411-A3D8-4209-BCDF-6152A452FEF2

P2860

Q26785420-1B57C27A-B38E-4183-8B40-002D3240CAFF

Q26785420-241884C8-5504-4D61-8789-DC81CFDBC5E5

Q26785420-27FF9FE3-DC08-4A9F-AD61-0519E3B2CE50

Q26785420-2DE575C7-0C83-4ECC-96F4-23B8BE5EB9EC

Q26785420-379988CD-ED16-4B92-8C9A-11882AF20702

Q26785420-46FA4A2A-2471-4D84-9CBC-A4DBB97DA7F1

Q26785420-4E296216-ACF1-4511-A918-4F36AA2227B6

Q26785420-5598ED73-8416-4325-8224-D8027C7F79DE

Q26785420-580E5760-F530-4760-BD2C-4602EAB9B498

Q26785420-5A3737B9-2CA0-42F5-8574-130BD24E4CBC

P304

Q26785420-625D872A-1664-4DA7-89C5-1B7DF31A196F

P31

Q26785420-69CF24AD-04A2-4760-99F1-C61ABDF6ECB1

Q26785420-90EC6D57-6CEC-4B1A-8734-22CB94B75460

P3181

Q26785420-A383C9FA-5EA9-4BE0-8D00-D5A51AC7B31D

P356

Q26785420-6786494D-DB65-4118-8932-5F4BF0F955FD

P407

Q26785420-77C6A388-448D-4452-BD0C-6A8BCDB31D09

P478

Q26785420-FFE7FA7C-26F9-4888-B715-E8557292BC5B

P5008

Q26785420-B21BE594-7D59-4192-A9DA-30AF20FF6ECB

P577

Q26785420-91A276BC-64A5-4C2C-ACAF-7F44569A96E8

P5875

Q26785420-E5143590-AEE4-4119-AB5D-B5AF2ECBF0BA

P698

Q26785420-8F05F3C7-76F1-4485-BC51-AEDC195F26F5

P921

Q26785420-57E78791-814E-426F-B039-B7799370844F

Q26785420-79DCCA9D-B49D-4003-AE3C-398CB86E6D3C

Q26785420-BA7E6FF3-A4B5-4763-865C-62D83C11ADD4

P932

Q26785420-699A41EE-67AC-4C0B-89D9-993ED966EC2E

P3181

P356

P1433

German medical science : GMS e-journal

P1476

Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology

@en

P2093

Hajo Hamer

http://www.w3.org/2001/XMLSchema#string

Hartmut Richter

http://www.w3.org/2001/XMLSchema#string

Karel Kostev

http://www.w3.org/2001/XMLSchema#string

Peyman Hadji

http://www.w3.org/2001/XMLSchema#string

Silvia Dombrowski

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries.

The epidemiology of epilepsy in Europe - a systematic review.

The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study.

Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction.

Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.

Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes.

Cost of disorders of the brain in Europe 2010.

Study of prevalence of epilepsy in children with type 1 diabetes mellitus.

Adherence and persistence in patients with severe osteoporosis treated with teriparatide.

Antiepileptic drugs in Australia: 2002-2007.

P304

Doc14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

451803

http://www.w3.org/2001/XMLSchema#string

P356

10.3205/000218

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281513171

http://www.w3.org/2001/XMLSchema#string

P698

26339224

http://www.w3.org/2001/XMLSchema#string

P921

P932

4549652

http://www.w3.org/2001/XMLSchema#string